Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.076 AUD | -2.56% | -11.63% | -6.17% |
03-20 | Australia's Tax Agency Publishes Ruling on Invex Therapeutics' Capital Return | MT |
02-16 | Invex Therapeutics Narrows Fiscal H1 Loss on Lower R&D Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-6.17% | 3.87M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- IXC Stock
- News Invex Therapeutics Ltd
- Invex Therapeutics Secures Approval for IIH EVOLVE Phase III Trial in France; Shares Rise 7%